-Reuters
HC Wainwright & Co. Reiterates Buy on Seagen, Maintains $180 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $180 price target.
Related Posts
Amazon’s Newark Airport Deal Succumbs To Unionization
Amazon.com, Inc (NASDAQ:AMZN) and the Port Authority of New York and New Jersey ended talks for a potential deal to develop…
BTIG Maintains Buy on Homology Medicines, Lowers Price Target to $12
BTIG analyst Robert Hazlett maintains Homology Medicines (NASDAQ: FIXX) with a Buy and lowers the price target from $29 to $12.BTIG analyst Robert Hazlett maintains Homology Medicines (NASDAQ:FIXX) with a Buy and lowers the price target from $29 to $
GXO Logistics Expands Partnership With Farfetch, Supporting Reebok’s Operations Across Europe
GXO Logistics Inc (NYSE: GXO) said it is expanding its relationship with Farfetch Limited (NYSE: FTCH) to support Reebok's omnichannel logistics throughout Europe from